W. De Wever (Leuven, Belgium), E. Grabczak (Warszawa, Poland), D. Gompelmann (Vienna, Austria)
Including the ALERT sessions (Abstracts Leading to Evolution in Respiratory Medicine Trials), these formats showcase important and very late-breaking clinical trial data from all respiratory disease areas. Presenters, session chairs and viewers will take part lively discussions on the presented trials.
Tezepelumab reduces mucus plugging in patients with uncontrolled, moderate-to-severe asthma: the phase 2 CASCADE study
L. H Nordenmark (Oslo, Norway), C. Emson (Gaithersburg, MD, United States), Å. Hellqvist (Gothenburg, Sweden), J. Johnston (Cambridge, United Kingdom), H. Greberg (Gothenburg, Sweden), J. Griffiths (Gaithersburg, MD, United States), J. Newell Jr (Iowa, United States), J. Parnes (California, United States), G. Colice (Gaithersburg, MD, United States), C. Brightling (Leicester, United Kingdom)
|    |
Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma: The INCA Sun randomized clinical trial
R. Costello (Dublin 9, Ireland), L. Heaney (Belfast, Ireland), D. Murphy (Cork, Ireland), E. Machale (Dublin, Ireland)
| |
Wrap-up by discussant and discussion
G. Brusselle (Ghent, Belgium)
| |
Comparative Effect of Lung volume reduction surgery for Emphysema and Bronchoscopic lung volume reduction with valve placement: the CELEB trial.
S. Buttery (London, United Kingdom), A. Lewis (London, United Kingdom), L. Latimer (Leicester, United Kingdom), S. Kemp (London, United Kingdom), P. Shah (London, United Kingdom), D. Waller (London, United Kingdom), K. Lau (London, United Kingdom), S. Jordan (London, United Kingdom), N. Greening (Leicester, United Kingdom), S. Rathinam (Leicester, United Kingdom), W. Banya (London, United Kingdom), J. Moxham (London, United Kingdom), A. Kirk (West Dumbartonshire, Scotland, United Kingdom), R. Bilancia (West Dumbartonshire, Scotland, United Kingdom), S. Tenconi (Sheffield, United Kingdom), K. Housley (Sheffield, United Kingdom), R. Lawson (Sheffield, United Kingdom), M. Steiner (Leicester, United Kingdom), N. Hopkinson (London, United Kingdom)
| |
Sustained health-related quality of life in patients with severe heterogenous emphysema treated with spiration valve system at 24-month follow-up (EMPROVE)
G. Criner (Philadelphia, United States), A. Delage (Sherbrooke, Canada), K. Voelker (Sarasota, Florida, United States), S. Martel (Quebec, Canada), E. The Emprove Trial Investigator Group (Philadelphia, United States)
| |
Wrap-up by discussant and discussion
I. Opitz (Zurich, Switzerland)
| |
A randomized controlled trial evaluating the benefit of cone beam CT guidance to electromagnetic navigation bronchoscopy for the diagnosis of pulmonary nodule
B. Bondue (Bruxelles, Belgium), O. Taton (Bruxelles, Belgium), F. Tannouri (Bruxelles, Belgium), M. Remmelink (Bruxelles, Belgium), D. Leduc (Bruxelles, Belgium)
| |
Endosonography with or without confirmatory mediastinoscopy for resectable lung cancerA randomized clinical trial
J. Annema (Amsterdam, Netherlands), J. Bousema (Veldhoven, Netherlands), M. Dijkgraaf (Amsterdam, Netherlands), E. Van Der Heijden (Nijmegen, Netherlands), A. Verhagen (Nijmegen, Netherlands), F. Van Den Broek (Veldhoven, Netherlands)
| |
Wrap-up by discussant and discussion
I. Opitz (Zurich, Switzerland)
| |